Cannabis Has Record-Setting Month

March 5, 2019 -- InvestorsHub NewsWire -- Microcap Speculators -- The cannabis industry continues to make large strides. Last year, Canada became the first industrialized country in the world to legalize recreational weed. Two-thirds of U.S. states have approved marijuana in some capacity with 66% of respondents polled in Gallup's October 2018 survey favoring the idea of legalizing marijuana.

Cannabis investors continue to show favor to this growth. Last month, 15 pot stocks rallied by at least 50% with many of the largest marijuana stocks up by a high-triple-digit or quadruple-digit percentage since 2016 began.

Looking for stocks that may receive a boost from investors in this industry, CleanSpark, Inc. (USOTC: CLSK) and their microgrid power solution for the cannabis industry that cuts the monthly electricity bill of indoor grow-houses by up to 82%, may be a good option to research. The company is not fully exposed to cannabis, as most of their revenue is driven from operations unrelated to cannabis. The company has been ranked in the top 10 microgrids by Navigant Research.

Today we are highlighting: CleanSpark, Inc. (USOTC: CLSK), GW Pharmaceuticals plc (NASDAQ: GWPH), HEXO Corp. (HEXO), CannTrust Holdings, Inc. (NYSE: CTST), and Canopy Growth Corporation (NYSE: CGC).

It’s been a busy few months for CleanSpark, Inc. (USOTC: CLSK) (Market Cap: $173.016M, Share Price: $4.17) has announced an up to $18 million deal with NYSE company MAC, which has completed an acquisition adding $3.6 million in gross sales to CLSK’s bottom line during early 2019 alone and several other achievements that have brought this microgrid growth play well off its $1.10 52-week low.

The company counts itself as one of the very few OTC companies on the LD Micro Index (only 4% of the 1000 companies are OTC listed). The increase in exposure means investors should research CLSK now.

______

GW Pharmaceuticals plc (NASDAQ: GWPH) (Market Cap: $5.707B, Share Price: $176.43) reported impressive numbers highlighted by its strong launch for cannabinoid oil Epidiolex in seizure treatment. Epidiolex generated $4.7 million in sales over two months.
_______

HEXO Corp. (HEXO) (Market Cap: $1.141B, Share Price: $5.55) is forming a joint venture with Molson Coors. The company is partnering with HEXO, which'll likely be a top-10 producer by peak annual output Molson Coors gets its foot in the door in a fast-growing industry, while giving HEXO the marketing leadership it needs.

_______

CannTrust Holdings, Inc. (NYSE: CTST) (Market Cap: $995M, Share Price: $9.02), a Canada-based cannabis producer, has just added itself to the list of Canadian producers to list on the NYSE. Further legitimizing an industry that was taboo only a few years ago.
________

Canopy Growth Corporation (NYSE: CGC) (Market Cap: $15.918B, Share Price: $46.80) announced earlier this week that it has named Hilary Black as its Chief Advocacy Officer, effective immediately. In her expanded role, Hilary's mandate includes driving patient advocacy efforts worldwide, executing the company's global corporate social responsibility strategy and leading the implementation of best practices for diversity & inclusion.

Legal Disclaimer:

This article was written by Regal Consulting, LLC (“Regal Consulting”). Regal Consulting has agreed to a three-month term consulting agreement with CLSK dated 9/12/18. The agreement calls for $10,000 in cash, and 30,000 restricted 144 shares of CLSK per month. Regal and CLSK have signed an amendment to extend the contract for twelve months starting 10/10/18, and increased the cash component to $20,000 per month. CLSK has paid an additional $12,000 for services provided in November. CLSK has paid an additional $88,000 for services provided in December. CLSK has paid an additional $100,000 for services for January. CLSK has paid an additional $80,000 for services for February. Regal was paid an additional $30,000 for March services and possibly compensated more for March in the future, at which time Regal will update this disclaimer. All payments were made directly by Clean Spark, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. CLSK was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.

http://www.regalconsultingllc.com/full legal disclaimer/

Microspeculators.com Full Legal Disclaimer Click Here.

Contact Information:

Company Name: Microcap Speculators

Contact Person: Media Manager

Email: info@microcapspeculators.com

Phone: 1-702-720-6310

Country: United States

Website: http://microcapspeculators.com/

GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Mar 2024 to Apr 2024